TSK (Tryptophan - Serotonin - Kynurenine) Biomarkers Assessment in Stroke

Completed

Phase N/A Results N/A

Summary of Purpose

Single-center, prospective, descriptive and biomedical research with controls, without health product. Depression is the second risk factor for stroke as tobacco smoking following hypertension. Peripheral abnormalities in serotonin parameters were described in depression and tobacco smoking. The investigators hypothesized dysregulations in pathways of serotonin (5-HT), which has notably complex vasomotor...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 16 November 2016.

1 Oct 2012 16 Sep 2016 1 Nov 2014 1 May 2016 1 Nov 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available

Contacts

Not available